Age-adjusted characteristics in patients with respiratory viral co-infection compared to mono-infection.

a<p>Reference category.</p>b<p>Back transformation of the mean age-adjusted natural log values analyzed, along with back transformed 95% confidence intervals.</p>c<p>Odds ratios not computed on variables with zero occurrences in a cell category.</p>d<p>Adjusted means and standard errors are presented.</p>e<p>NAD: No acute disease; IO: interstitial opacities; FASD: focal airspace disease; MFASD: multifocal airspace disease.</p

Respiratory viral co-infection (N = 49).

<p>Respiratory viral co-infection (N = 49).</p

Age-adjusted characteristics in patients with pH1N1 influenza viral co-infection compared to pH1N1 mono-infection.

a<p>Reference category.</p>b<p>Back transformation of the mean age-adjusted natural log values analyzed, along with back transformed 95% confidence intervals.</p>c<p>Odds ratios not computed on variables with zero occurrences in a cell category.</p>d<p>Adjusted means and standard errors are presented.</p>e<p>NAD: No acute disease; IO: interstitial opacities; FASD: focal airspace disease; MFASD: multifocal airspace disease.</p

Age-adjusted treatments and outcomes in patients with pH1N1 influenza viral co-infection compared to pH1N1 mono-infection.

a<p>Odds Ratios not computed on variables with zero occurrences in a cell category.</p>b<p>Back transformation into days, of the mean age-adjusted natural log values analyzed, along with the back transformed 95% confidence intervals. Analysis conducted on data available on 114 of 116 admitted to ICU.</p

Distribution of respiratory virus co-infection versus mono-infection relative to age group.

<p>Distribution of respiratory virus co-infection versus mono-infection relative to age group.</p

Distribution of pH1N1 co-infection versus pH1N1 mono-infection relative to age group.

<p>Distribution of pH1N1 co-infection versus pH1N1 mono-infection relative to age group.</p

Independent predictors of treatment for a secondary bacterial pneumonia comparing patients with non-pH1N1 mono-infection to other patient groups.

a<p>Age as Nat log (age +1) to adjust for significant variance at the group level and between groups.</p

Age-adjusted treatments and outcomes in patients with respiratory viral co-infection compared to mono-infection.

a<p>Odds Ratios not computed on variables with zero occurrences in a cell category.</p>b<p>Back transformation into days, of the mean age-adjusted natural log values analyzed, along with the back transformed 95% confidence intervals. Analysis conducted on data available on 114 of 116 admitted to ICU.</p

Conceptual framework.

<p>Conceptual framework.</p

EFA item loadings for 4-factor solution of adherence monitoring items, FTP sample from vaginal ring clinical trials only.

<p>EFA item loadings for 4-factor solution of adherence monitoring items, FTP sample from vaginal ring clinical trials only.</p